The estimated Net Worth of Daniel M Hancock is at least 951 千$ dollars as of 29 April 2022. Mr. Hancock owns over 2,708 units of CryoPort Inc stock worth over 113,251$ and over the last 6 years he sold CYRX stock worth over 0$. In addition, he makes 837,656$ as Director at CryoPort Inc.
Daniel has made over 7 trades of the CryoPort Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 2,708 units of CYRX stock worth 21,095$ on 29 April 2022.
The largest trade he's ever made was exercising 20,000 units of CryoPort Inc stock on 7 June 2021 worth over 194,600$. On average, Daniel trades about 3,207 units every 15 days since 2019. As of 29 April 2022 he still owns at least 14,538 units of CryoPort Inc stock.
You can see the complete history of Mr. Hancock stock trades at the bottom of the page.
Daniel M. Hancock is Director of the Company. Mr. Hancock was appointed to Cryoport’s board of directors in January 2019 and serves as member of the Audit Committee and Scientific and Technology Committee. Mr. Hancock is currently President of DMH Strategic Consulting LLC. He retired from General Motors ("GM") in 2011, after 43 years of service in GM's powertrain engineering and general management functions. His last position with GM was Vice President, Global Strategic Product Alliances. During this period, he served as Chairman of GM's DMAX and VM Motori diesel engine joint ventures with Isuzu and Fiat, respectively. Mr. Hancock's previous appointments at GM included: Vice President, Global Powertrain Engineering; CEO, Fiat-GM Powertrain; and President, Allison Transmission Division. Mr. Hancock is a director of Westport Fuel Systems (NASDAQ WPRT), a Vancouver, B.C. based global supplier of clean gaseous fuel parts, and systems for the transportation industry. He is also serving as chairman of the board of SuperTurbo Technologies, Inc., a Loveland, CO based privately-held developer of advanced turbo compounding systems for engines and director of Achates Power, Inc., a San Diego, CA headquartered privately-held developer of innovative opposed-piston, two-stroke diesel engines. In addition, Mr. Hancock serves in an advisory capacity to several global suppliers to the automotive and commercial vehicle industries. He was President of SAE International in 2014 and is a member of the National Academy of Engineering. He received a master's degree in mechanical engineering from Massachusetts Institute of Technology (MIT) and a bachelor's degree also in mechanical engineering from General Motors Institute (now Kettering University), Michigan.
As the Director of CryoPort Inc, the total compensation of Daniel Hancock at CryoPort Inc is 837,656$. There are 3 executives at CryoPort Inc getting paid more, with Jerrell Shelton having the highest compensation of 3,839,460$.
Daniel Hancock is 69, he's been the Director of CryoPort Inc since 2019. There are 3 older and 6 younger executives at CryoPort Inc. The oldest executive at CryoPort Inc is Richard Berman, 77, who is the Lead Independent Director.
Daniel's mailing address filed with the SEC is C/O CRYOPORT INC., 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027.
Over the last 12 years, insiders at CryoPort Inc have traded over 202,268,038$ worth of CryoPort Inc stock and bought 80,292 units worth 196,910$ . The most active insiders traders include Holdings Ii L.P.Blackstone ...、Richard J Berman、Jerrell Shelton. On average, CryoPort Inc executives and independent directors trade stock every 39 days with the average trade being worth of 414,958$. The most recent stock trade was executed by Robert J Hariri on 19 August 2024, trading 1,000 units of CYRX stock currently worth 9,470$.
cryoport delivers an innovative and complete outsourced frozen shipping solution for biological materials. this breakthrough combination replaces outdated dry ice shipping, virtually eliminates the risk of cell degradation and revolutionizes deep frozen logistics. we combine the technology of liquid nitrogen dry vapor shippers with the most advanced logistics management platform in the industry. when added with our logistics expertise, we provide a complete outsourced solution that advances deep-frozen shipping for the life science community. whether your business is bio-pharmaceuticals, clinical trials, research or reproductive medicine, you want to focus on your core mission. cryoport will help you transport life.
CryoPort Inc executives and other stock owners filed with the SEC include: